On December 31, 2020, Changzhou Tongtai Biopharmaceutical Technology Co., Ltd. (871354), an enterprise on the new third board, issued a fixed increase plan: it plans to issue 5 million new shares at a price of 6 yuan per share, and plans to raise 30 million yuan. The subscriber is Guojian capital Wuhan Guojian Guanggu phase I health industry investment management center (limited partnership) of Sinopharm group.

Changzhou Tongtai Biopharmaceutical Technology Co., Ltd., established in October 2006, is located in Changzhou Airport Industrial Park, Changzhou high tech Zone. The company is committed to the production, R & D and sales of veterinary vaccines, pet diagnostic reagents, pet nutrition and beauty products.